Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosisResearch in context
Background: Histone deacetylase 4 (HDAC4) has been proposed as a target for Amyotrophic Lateral Sclerosis (ALS) because it mediates nerve-skeletal muscle interaction and since its expression in skeletal muscle correlates with the severity of the disease. However, our recent studies on the skeletal m...
Main Authors: | Eva Pigna, Elena Simonazzi, Krizia Sanna, Krzysztof Marian Bernadzki, Tomek Proszynski, Constantin Heil, Daniela Palacios, Sergio Adamo, Viviana Moresi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-02-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396419300441 |
Similar Items
-
Increasing autophagy does not affect neurogenic muscle atrophy
by: Eva Pigna, et al.
Published: (2018-08-01) -
Denervation does not induce muscle atrophy through oxidative stress
by: Eva Pigna, et al.
Published: (2017-03-01) -
Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral SclerosisResearch in context
by: Matthew Salter, et al.
Published: (2018-07-01) -
Histone deacetylase inhibitors as potential treatment for spinal muscular atrophy
by: Jafar Mohseni, et al.
Published: (2013-01-01) -
Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis
by: Thaddaeus Kwan, et al.
Published: (2020-10-01)